Summary:
In overweight or obese adults without chronic illness, short-term American black elderberry juice (EBJ) supplementation significantly enhanced transcriptional responses to meal intake and enriched pathways regulating metabolic flexibility compared to placebo (PL) beverage during a 5-week crossover trial, though it was associated with no significant adverse effects reported.
| PICO | Description |
|---|---|
| Population | Overweight or obese adults (BMI >25 kg/m²) without chronic illnesses. |
| Intervention | American black elderberry juice (EBJ), consumed twice daily for one week in a randomized, crossover feeding trial. |
| Comparison | Placebo beverage consumed under identical conditions during a separate intervention week, with a washout period in between. |
| Outcome | EBJ consumption led to 234 differentially expressed genes related to the fasted-to-fed transition versus 59 genes for PL. Transcriptomic analysis revealed enhanced enrichment of insulin, FoxO, and PI3K-Akt signaling pathways, with 27 KEGG pathways significantly modulated compared to 7 for PL, reflecting improved metabolic flexibility at the transcriptome level. |
Clinical Context
Metabolic flexibility is the body’s capacity to switch efficiently between burning carbohydrate and fat in response to feeding and fasting. This adaptability is blunted in obesity and insulin resistance, and its impairment is an early step on the path to type 2 diabetes. Foods rich in anthocyanins and other polyphenols, such as American black elderberry, have attracted interest for potentially improving insulin signalling, reducing oxidative stress, and supporting healthier metabolism. However, much of the supporting evidence is preclinical, and human data on how such foods influence the dynamic, meal-driven metabolic response are limited. This randomised crossover trial addresses that gap by using a meal-challenge transcriptomic readout to test whether short-term elderberry juice enhances metabolic flexibility in overweight adults.
Clinical Pearls
- Stronger transcriptional response: Elderberry juice produced 234 differentially expressed genes in the fasted-to-fed transition, roughly four times the 59 genes seen with placebo, indicating a far more dynamic metabolic response to a meal.
- Insulin-related pathways: Transcriptomic analysis showed enrichment of the insulin, FoxO, and PI3K-Akt signalling pathways, all central to insulin action and fuel substrate handling.
- Broad pathway modulation: A total of 27 KEGG pathways were significantly modulated with elderberry juice versus only 7 with placebo, reflecting wider engagement of metabolic regulatory networks.
- Favourable safety: The one-week, twice-daily intervention was well tolerated with no significant adverse effects, consistent with elderberry juice’s profile as a food-based supplement.
Practical Application
These findings are mechanistic and hypothesis-generating rather than a basis for clinical recommendation. The study measured changes in gene expression after a meal, not clinical endpoints such as weight, fasting glucose, or insulin sensitivity, so it would be premature to advise elderberry juice as a treatment for metabolic dysfunction. That said, elderberry juice is a generally safe, polyphenol-rich beverage, and clinicians can reasonably regard it as a benign component of an overall healthy diet for interested patients. Important caveats include the sugar content of some commercial juices and the fact that raw or improperly processed elderberries can be toxic, so only properly prepared products should be used. Any metabolic benefit remains unproven at the clinical level.
Broader Evidence Context
The results fit within the broader nutrigenomics and polyphenol literature, in which anthocyanin-rich foods such as berries and other flavonoid sources have been associated with improved insulin sensitivity, reduced inflammation, and favourable shifts in metabolic signalling. Enrichment of the insulin, FoxO, and PI3K-Akt pathways is biologically coherent with these prior observations. However, most of this evidence rests on surrogate or molecular markers rather than hard clinical outcomes, and dietary guidelines do not endorse elderberry or similar supplements as therapies for metabolic disease. The present study is consistent with prior work suggesting that polyphenol-rich foods can modulate metabolic gene expression, while underscoring that translation to meaningful clinical benefit still requires demonstration.
Study Limitations
- The intervention lasted only one week per arm, far too short to establish durable or clinically meaningful effects.
- Outcomes were transcriptomic surrogates; the study did not measure glucose, insulin sensitivity, weight, or other clinical endpoints directly.
- The clinical significance of the differentially expressed genes and modulated pathways is uncertain and may not translate into health benefit.
- Participants were overweight or obese adults without chronic illness, limiting generalisability to those with established metabolic disease.
- Sample size, dosing details, and any funding or conflict-of-interest considerations are not described in the summary, constraining interpretation.
Bottom Line
One week of American black elderberry juice produced a broader and more dynamic meal-responsive gene-expression profile than placebo, enriching insulin-related pathways and suggesting improved metabolic flexibility at the transcriptome level, with no adverse effects. These are encouraging but purely molecular findings over a very short period. Elderberry juice is safe as part of a healthy diet, yet larger, longer trials measuring clinical metabolic outcomes are needed before any therapeutic claim.
Source: Teets, Christy, et al. “One-Week Elderberry Juice Intervention Promotes Metabolic Flexibility in the Transcriptome of Overweight Adults During a Meal Challenge.” Read article here.
